IU School of Medicine forms research collaboration with Lung Biotechnology PBC

(Indiana University) IU School of Medicine recently secured a four-year, $9 million sponsored research agreement from Lung Biotechnology PBC, a wholly owned subsidiary of United Therapeutics Corporation.